Following consultation with the Therapeutic Goods Administration (TGA), AstraZeneca is conducting a sponsor-initiated recall on Xylocaine 1% with Adrenaline 1:200,000 20ml Injection, packs of 5 vials – Batch Number 306079. The recall is being undertaken because AstraZeneca has identified that the product may potentially be mixed with a vial of Marcain 0.5% with Adrenaline 1:200,000 20ml Injection.  For [...]

Since the release of the Fourth Community Pharmacy Agreement in 2005, there has been significant concern that it doesn’t reflect the process for medication management in Aged Care Facilities and Private Hospitals. In light of this, the Australian Government has released a discussion paper proposing fundamental changes to the supply of PBS medicines in these [...]

Short CIRCUIT, the ebulletin companion to our clinical newsletter, CIRCUIT, continues to be popular with over 4,000 bulletins being read by our subscribers in 2007.
Our two most recent bulletins both covered safety concerns surrounding Aprotinin (Trasylol). Short CIRCUIT again proved an excellent communication tool as part of our complete communication strategy, reinforcing information which had [...]